Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PRLD compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
PRLD
Prelude Therapeutics Inc
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
PRLD
Prelude Therapeutics Inc
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
PRLD
Prelude Therapeutics Inc
Change
3.57
▼
−12.38%
· post 3.57
Mkt cap
$325.6M
Revenue
$6M
Q2 FY26
Revenue
—
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,361.90
Closed
Nov 5 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 5 '26
PRLD
Prelude Therapeutics Inc
vs
LLY
ELI Lilly & Co
3.57
▼
−12.38%
post 3.57
Price
1,371.32
▼
−3.29%
post 1,361.90
$325.6M
Mkt cap
$1.3T
Q2 FY26
$6M
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
PRLD
3.57
▼
−12.38%
vs
LLY
1,371.32
▼
−3.29%
Closed
Nov 5 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PRLD, solid
LLY, dashed